Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H-H Brackmann

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
The American Journal of Gastroenterology|December 1, 1996
Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIVJ K Rockstroh, U Spengler, T Sudhop, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 3, 1999
Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitorsJ Batlle, M F Lopez, H H Brackmann, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII geneO El-Maarri, U Herbiniaux, J Graw, et al.
The New England Journal of Medicine|December 27, 1990
Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study GroupR S Schwartz, C F Abildgaard, L M Aledort, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1977
10. Recommendations on home treatment of hemophiliasJ P Allain, M Blombäck, H H Brackmann, et al.
Human Gene Therapy|January 20, 1997
Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cellsD R Hurwitz, M Kirchgesser, W Merrill, et al.
Thrombosis and Haemostasis|January 12, 2001
Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complexJ Oldenburg, B von Brederlow, A Fregin, et al.
Blood|July 27, 2000
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factorM Jacquemin, R Lavend'homme, A Benhida, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
The American Journal of Gastroenterology|December 1, 1996
Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIVJ K Rockstroh, U Spengler, T Sudhop, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 3, 1999
Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitorsJ Batlle, M F Lopez, H H Brackmann, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII geneO El-Maarri, U Herbiniaux, J Graw, et al.
The New England Journal of Medicine|December 27, 1990
Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study GroupR S Schwartz, C F Abildgaard, L M Aledort, et al.
Scandinavian Journal of Haematology. Supplementum|January 1, 1977
10. Recommendations on home treatment of hemophiliasJ P Allain, M Blombäck, H H Brackmann, et al.
Human Gene Therapy|January 20, 1997
Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cellsD R Hurwitz, M Kirchgesser, W Merrill, et al.
Thrombosis and Haemostasis|January 12, 2001
Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complexJ Oldenburg, B von Brederlow, A Fregin, et al.
Blood|July 27, 2000
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factorM Jacquemin, R Lavend'homme, A Benhida, et al.
Pageof 14